EIF2AK2 and cholangiocarcinoma: Unexpectedly, vtRNA2-1 levels were demonstrated to be suppressed (and hence PKR activity increased) in cholangiocarcinoma cells and in clinical samples from cholangiocarcinoma patients [78].